Module Database Search
| MODULE DESCRIPTOR | |||
|---|---|---|---|
| Module Title | |||
| Clinical Therapeutics 1 | |||
| Reference | PL3001 | Version | 1 |
| Created | April 2022 | SCQF Level | SCQF 9 |
| Approved | June 2022 | SCQF Points | 30 |
| Amended | August 2021 | ECTS Points | 15 |
| Aims of Module | |||
|---|---|---|---|
| To develop knowledge and understanding of the scientific principles and concepts of pharmacology, pharmacokinetics and evidence-based therapeutics and integration of these into therapeutic plans for individual patients. | |||
| Learning Outcomes for Module | |
|---|---|
| On completion of this module, students are expected to be able to: | |
| 1 | Demonstrate a critical understanding of the fundamentals of pharmacology, pharmacokinetics and evidence-based therapeutics. |
| 2 | Justify suitable evidence-based therapeutic strategies of commonly occurring disease states. |
| 3 | Demonstrate the ability to use clinical skills including communication, consultation, data gathering from case notes, and physical assessment to improve health outcomes. |
| Indicative Module Content |
|---|
| Topics include the principles underpinning the pharmacodynamics and pharmacokinetics of therapeutics of the nervous system, acute pain, infectious diseases (including antimicrobials), the immune system and musculoskeletal diseases. Evidence-based therapeutics will include: identification of the goals of therapy, drug selection, adverse drug reactions, side effects, new therapies, monitoring and non-pharmacological management of common diseases in the above systems. |
| Module Delivery |
|---|
| This module is delivered with a mix of lectures and case study-based tutorials and practical lab sessions, supplemented by formative self-assessment. |
| Indicative Student Workload | Full Time | Part Time |
|---|---|---|
| Contact Hours | 70 | N/A |
| Non-Contact Hours | 230 | N/A |
| Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
| TOTAL | 300 | N/A |
| Actual Placement hours for professional, statutory or regulatory body |
| ASSESSMENT PLAN | |||||
|---|---|---|---|---|---|
| If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
| Component 1 | |||||
| Type: | Examination | Weighting: | 50% | Outcomes Assessed: | 1, 2 |
| Description: | A closed book written examination | ||||
| Component 2 | |||||
| Type: | Practical Exam | Weighting: | 50% | Outcomes Assessed: | 3 |
| Description: | A practical assessment of clinical skills. | ||||
| MODULE PERFORMANCE DESCRIPTOR | |
|---|---|
| Explanatory Text | |
| A minimum of grade D or better is required to pass this module. | |
| Module Grade | Minimum Requirements to achieve Module Grade: |
| A | When the grade for Component 1(EX1) is an A and a PASS in Component 2(PE1). |
| B | When the grade for Component 1(EX1) is an B and a PASS in Component 2(PE1). |
| C | When the grade for Component 1(EX1) is an C and a PASS in Component 2(PE1). |
| D | When the grade for Component 1(EX1) is an D and a PASS in Component 2(PE1). |
| E | When the grade for Component 1(EX1) is an E and a PASS in Component 2(PE1). |
| F | When the grade for Component 1(EX1) is an F and/or an unsuccessful attempt (i.e. a Fail) at Component 2(PE1). |
| NS | Non-submission of work by published deadline or non-attendance for examination |
| Module Requirements | |
|---|---|
| Prerequisites for Module | Successful completion of MPharm Stage 1 or equivalent. |
| Corequisites for module | None. |
| Precluded Modules | None. |
| INDICATIVE BIBLIOGRAPHY | |
|---|---|
| 1 | GOLDACRE, B., 2008. Bad Science. First edition . London: HarperCollins. |
| 2 | NEAL, M.J., 2015. Medical Pharmacology at a Glance. Eight edition. Oxford: Wiley-Blackwell. |
| 3 | RANG, H. P. RITTER, J.M., FLOWER, R.J. and HENDERSON, G., 2015. Rang and Dale's Pharmacology. Eight edition. London: Churchill Livingstone. |
| 4 | WHITTLESEA, C. and HODSON, K., 2019. Clinical Pharmacy and Therapeutics. Sixth edition. Edinburgh: Churchill Livingstone. |